Akoya Biosciences, Inc.
AKYA
$1.24
$0.119.74%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 35.04M | 35.90M | 45.22M | 61.58M | 83.13M |
Total Receivables | 13.78M | 12.79M | 16.55M | 13.47M | 16.99M |
Inventory | 24.32M | 25.21M | 24.80M | 22.99M | 17.88M |
Prepaid Expenses | 3.26M | 2.97M | 2.94M | 3.79M | 3.79M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 331.00K | -- | -- | -- | -- |
Total Current Assets | 76.73M | 76.86M | 89.51M | 101.83M | 121.79M |
|
|||||
Total Current Assets | 76.73M | 76.86M | 89.51M | 101.83M | 121.79M |
Net Property, Plant & Equipment | 12.98M | 13.97M | 14.47M | 15.88M | 20.66M |
Long-term Investments | 18.26M | 18.26M | 18.26M | 18.26M | 18.26M |
Goodwill | 18.26M | 18.26M | 18.26M | 18.26M | 18.26M |
Total Other Intangibles | 14.56M | 15.27M | 15.99M | 16.70M | 17.41M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.47M | 2.21M | 2.02M | 2.08M | 2.25M |
Total Assets | 125.01M | 129.97M | 143.75M | 154.75M | 180.37M |
|
|||||
Total Accounts Payable | 8.76M | 8.76M | 9.79M | 10.75M | 11.78M |
Total Accrued Expenses | 8.50M | 6.77M | 10.45M | 7.14M | 10.43M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.28M | 3.68M | 3.32M | 3.37M | 3.45M |
Total Finance Division Other Current Liabilities | 8.90M | 8.79M | 9.18M | 11.93M | 9.70M |
Total Other Current Liabilities | 8.90M | 8.79M | 9.18M | 11.93M | 9.70M |
Total Current Liabilities | 29.44M | 27.99M | 32.74M | 33.19M | 35.35M |
|
|||||
Total Current Liabilities | 29.44M | 27.99M | 32.74M | 33.19M | 35.35M |
Long-Term Debt | 76.18M | 75.90M | 75.68M | 75.47M | 75.25M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 4.68M | 5.34M | 5.69M | 6.35M | 7.00M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 7.10M | 7.11M | 7.38M | 7.02M | 9.00M |
Total Liabilities | 117.41M | 116.34M | 121.50M | 122.03M | 126.60M |
|
|||||
Common Stock & APIC | 293.02M | 290.86M | 288.97M | 286.29M | 283.84M |
Retained Earnings | -285.44M | -277.24M | -266.70M | -253.56M | -230.07M |
Treasury Stock & Other | 7.00K | 8.00K | -12.00K | -16.00K | -- |
Total Common Equity | 7.60M | 13.63M | 22.25M | 32.72M | 53.77M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 7.60M | 13.63M | 22.25M | 32.72M | 53.77M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 7.60M | 13.63M | 22.25M | 32.72M | 53.77M |
|